The company is a specialized veterinary biological products manufacturer integrating R&D, production, sales and service. The company was founded in 1981, and its predecessor was Shanghai Songjiang Biopharmaceutical Factory. The company is a designated enterprise approved by the Ministry of Agriculture to produce biological products for veterinary use in Shanghai and a production base for the prevention and treatment of major animal epidemics set up by the Ministry of Agriculture in Shanghai. The company has a complete product line, perfect product structure, a total of 23 products in the two categories of poultry and livestock, and has a full-service product base and capabilities. In May 2015, the company successfully entered the domestic A-share main board market. Currently, the total share capital is 644 million shares. The company's main business is divided into two different segments: “Animal Insurance” and “Human Insurance”. The main products are mainly swine vaccines. The company is a high-tech enterprise in Shanghai, a leading agricultural industrialization enterprise in Shanghai, a civilized enterprise in Shanghai, a contract-abiding and credit-worthy enterprise in Shanghai, and an enterprise that meets the standards for harmonious labor relations in Shanghai. The company's R&D center has been recognized as the Shanghai Enterprise Technology Center, the Shanghai Veterinary Biological Products Engineering Technology Research Center, the Shanghai Veterinary Vaccine Manufacturing Process Professional Technical Service Platform, and the Shanghai Academician Expert Workstation.